Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
about
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.Efficacy and safety of HD-MTX based systemic chemotherapy regimens: retrospective study of induction therapy for primary central nervous system lymphoma in Chinese.
P2860
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
@ast
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
@en
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
@nl
type
label
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
@ast
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
@en
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
@nl
prefLabel
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
@ast
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
@en
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
@nl
P2860
P1433
P1476
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
@en
P2093
Antonio Omuro
Jerome J Graber
P2860
P304
P356
10.2165/11589030-000000000-00000
P577
2011-06-01T00:00:00Z
P6179
1043604474